|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 231/38 | |
| A61K 31/415 | |||
| A61P 29/00 |
| (11) | Number of the document | 3484853 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17742277.1 |
| Date of filing the European patent application | 2017-07-13 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2017/052055 |
| Date | 2017-07-13 |
| (87) | Number | WO 2018/011578 |
| Date | 2018-01-18 |
| (30) | Number | Date | Country code |
| 201612238 | 2016-07-14 | GB |
| (72) |
SULEIMAN, Osama, GB
PEREZ, Lucia Romero, GB
HARLACHER, Cornelius Stephan, CH
JONES, Stewart, GB
|
| (73) |
Mereo BioPharma 1 Limited,
1 Cavendish Place, London, Greater London W1G 0QF,
GB
|
| (54) | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
| METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |